In contrast, the CD34+ fraction with high ROS levels and low GSH content (ROShi GSHlo) appeared to be less expressed (mean percentage: 13%) in AML patients than ROSlo GSHhi (p = 0.007) and ROSlo GSHlo (p = 0.0002) fractions (Fig. 1b). Here, CD34 is linked to acute myeloid leukemia.